Weinreb R N, Levin L A
Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla 92093-0946, USA.
Arch Ophthalmol. 1999 Nov;117(11):1540-4. doi: 10.1001/archopht.117.11.1540.
Treatment of glaucoma continues to be directed at lowering intraocular pressure to decrease the likelihood of disease progression. In the future intraocular pressure reduction might be augmented by other therapeutic approaches. Interest has been increasing in preventing progression of glaucomatous optic neuropathy using approaches based on the premise that glaucoma is a neurodegenerative disease. Neuroprotection of the glaucomatous optic nerve therefore would be an adjuctive therapeutic paradigm for use with conventional intraocular pressure-lowering treatments or by itself.
青光眼的治疗仍然旨在降低眼压,以减少疾病进展的可能性。未来,降低眼压可能会通过其他治疗方法得到加强。基于青光眼是一种神经退行性疾病这一前提,采用相关方法来预防青光眼性视神经病变的兴趣一直在增加。因此,青光眼视神经的神经保护将成为一种辅助治疗模式,可与传统的降低眼压治疗联合使用,也可单独使用。